Healthcare Equipment and Supplies
Company Overview of Animas Corporation
Animas Corporation develops and manufactures insulin delivery products. The company offers insulin pumps and meter-remotes, infusion sets, and glucose management systems; and other products and accessories, including insulin pump skins, belts, clips, cases, bags, and more. It also provides ezManager Max, diabetes management software, which enables to manage and analyze diabetes information from insulin pumps and glucose meters; and Diasend, a Web-based diabetes management system that allows to store, review, and print insulin pump and blood glucose meter data on the Diasend Website. Animas Corporation offers its products through distributors in the United States and internationally. The comp...
200 Lawrence Drive
West Chester, PA 19380
Founded in 1996
Key Executives for Animas Corporation
Chairman of the Board, Chief Executive Officer and President
Vice President of Operations
Vice President and General Counsel
Compensation as of Fiscal Year 2015.
Animas Corporation Key Developments
Animas Corporation's Animas(R) Vibe(TM) Insulin Pump and Continuous Glucose Monitoring System Receives FDA Approval
Dec 1 14
Animas Corporation announced FDA approval of the Animas(R) Vibe(TM) insulin pump and Continuous Glucose Monitoring (CGM) system for the management of insulin-requiring diabetes in adults ages 18 and older. As the first and only integrated system featuring Dexcom G4(R) PLATINUM sensing technology with proven accuracy, Animas(R) Vibe(TM) allows patients to view glucose data and administer insulin right from the pump; simplifying and aiding their ability to make more informed decisions to fine tune insulin delivery and manage their diabetes. The Animas(R) Vibe(TM) system provides patients with their latest glucose readings on the pump screen and a complete view of glucose highs, lows, and rates of change over time. This information complements fingerstick testing results and can be used to help guide immediate and long-term insulin delivery therapy adjustments. CGM technology measures glucose levels every five minutes and provides real-time glucose values, as well as trend information. CGM has been shown to improve glycemic control in adult patients 25 years and older via lower HbA1c levels, less frequent hypoglycemia, and reduced glucose variability. Animas(R) Vibe(TM) also offers precise insulin dosing with a low basal increment of 0.025 U/hr across all available ranges (0.025 U/hr to 25.00 U/hr) and a low bolus increment of 0.05 U across all available bolus ranges (0.05 U to 35.00 U). Animas(R) Vibe(TM) users can also personalize dosing by choosing individual insulin-to-carb ratios, insulin sensitivity factors, and blood glucose targets in 30-minute increments with up to 12 personal settings. Additional key features of Animas(R) Vibe(TM) include: Dexcom CGM sensor technology is approved for up to seven days of continuous wear with one of the smallest introducer needles on the market. With Mean ARD (Absolute Relative Difference) as the industry's standard for measuring CGM accuracy, Dexcom's 13% Mean ARD provides exceptional performance and accuracy for reliable results; Waterproof up to 12 feet for up to 24 hours; Dexcom G4(R) PLATINUM transmitter is water resistant up to 8 feet for 24 hours; First and only CGM-enabled insulin pump with a high-contrast color screen, featuring color-coded graphs and arrows to indicate direction and rate of glucose change, revealing trends at a glance; Customizable alarms to indicate high and low glucose levels.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries